CDC20 and CCNB1 Overexpression as Prognostic Markers in Bladder Cancer
<b>Background:</b> Bladder cancer (BC) is one of the ten most common cancers worldwide, with a high recurrence rate and significant variation in clinical outcomes based on tumor grade and stage. This study aimed to investigate the gene expression profiles at different cancer stages to as...
Saved in:
Main Authors: | Hatice Sevim Nalkiran, Ilknur Biri, Ihsan Nalkiran, Hakki Uzun, Sumeyye Durur, Recep Bedir |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/15/1/59 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mutation in CDC42 Gene Set as a Response Biomarker for Immune Checkpoint Inhibitor Therapy
by: Kun Wang, et al.
Published: (2025-01-01) -
Functional Analysis and Experimental Validation of the Prognostic and Immune Effects of the Oncogenic Protein CDC45 in Breast Cancer
by: Zhang JN, et al.
Published: (2025-01-01) -
Comprehensive multi-omics analysis showed that CDC6 is a potential prognostic and immunotherapy biomarker for multiple cancer types including HCC
by: Chenxuan Li, et al.
Published: (2025-03-01) -
Identification and Characterization of a Novel Rat MAVS Variant Modulating NFκB Signaling
by: Ihsan Nalkiran, et al.
Published: (2025-01-01) -
Underlying and contributing causes of mortality from CDC WONDER—Insights for researchers
by: Abdul Mannan Khan Minhas, et al.
Published: (2025-02-01)